In 2023, Hua Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Hua Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Hua Medicine amounted to 435.747 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Hua Medicine increased by 32.24%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Hua Medicine were 19.201 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2021, Hua Medicine's Scope 1 emissions have increased by 26.41%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Hua Medicine's Scope 1 emissions increased by 11.83%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Hua Medicine reported Scope 2 greenhouse gas (GHG) emissions of 416.546 tCOâ‚‚e without specifying the calculation method.
Since 2021, Hua Medicine's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hua Medicine 's emissions have plateaued with no significant change in its energy consumption footprint.
Compared to the previous year (2022), Hua Medicine's Scope 2 emissions (Unspecified Calculation Method) rose by 33.37% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2023, Hua Medicine reported its Scope 2 emissions using an unspecified methodology.